Healthy Lifestyle Can Help People at Risk for Dementia, Study Finds

Summers aren’t just feeling hotter—they are hotter, and the data backs it up. Heat waves are hitting the U.S. more often and lasting longer than they did 40 years ago, leaving people like Duane Stilwell in Arizona sweating (and worrying) through each record-breaking season. Experts are stepping in with practical advice on how to handle the rising temps, because this isn’t just discomfort—it’s a growing health and safety challenge.

Editor’s Note: Heat waves aren’t just a nuisance anymore; they’re a symptom of a bigger problem. If you’ve noticed your AC working overtime or your city feeling like an oven, this story explains why—and how to stay safe. It’s a wake-up call for communities to adapt, because these scorching summers aren’t going away.

William J. Rutter, a trailblazer in biotechnology whose work laid the groundwork for gene-based medicine, has passed away at 97. He co-founded Chiron Corporation, a company instrumental in developing some of the first genetically engineered vaccines, including one for hepatitis B. His research helped revolutionize how we approach disease prevention and treatment.

Editor’s Note: Rutter’s contributions weren’t just academic—they saved lives. His work on recombinant DNA technology paved the way for modern vaccines and therapies, making him a key figure in the biotech boom. Even if you’ve never heard his name, his impact is in medicine cabinets and doctors' offices worldwide. This isn’t just an obituary; it’s a reminder of how foundational science shapes everyday health.

A simple scan called a coronary artery calcium test can give you a clearer picture of your heart attack risk than traditional methods—yet many doctors aren’t using it as much as they could. Some heart specialists argue this tool, which detects plaque buildup in arteries, could save lives by catching risks earlier.

Editor’s Note: Heart disease is still a leading killer, but this scan could help people take action before it’s too late. The fact that it’s underused suggests a gap between what’s available and what’s actually reaching patients—something worth paying attention to if you’re proactive about your health.

A new study in The Lancet warns that liver cancer cases could double in the coming years—but here’s the hopeful twist: over half of those cases might be avoidable. Researchers found that 60% of liver cancers are linked to preventable risk factors like hepatitis infections, alcohol use, and obesity. So while the projections sound alarming, there’s a clear roadmap to curb the trend.

Editor’s Note: Liver cancer doesn’t always make headlines like some other cancers, but it’s deadly and on the rise. The good news? We already know how to prevent a big chunk of cases—through vaccination (like for hepatitis B), early treatment, and lifestyle changes. This isn’t just a doom-and-gloom stat; it’s a call to action for better healthcare policies and personal choices. If governments and individuals step up, we could save thousands of lives.

The U.S. is set to impose a 15% tariff on European-made pharmaceutical products next month, a move that could hit drugmakers hard—costing them billions—and may trickle down to higher prices for consumers. The tariffs, part of broader trade tensions, target an industry already under scrutiny for high drug costs.

Editor’s Note: This isn’t just about trade wars—it’s about your wallet. If drug companies pass these costs on, Americans could end up paying even more for medications, many of which have no easy substitutes. At a time when drug affordability is already a hot-button issue, this could add fuel to the fire.